EPO Patents = 3

Trademarks = 15

Forward Citations = 24

Loading Chart...

29 inventors (with patents filed for the assignee):

Vipin Suri (7 out of 7 patents)

Dexue Sun (7 out of 7 patents)

Dan Jun Li (6 out of 6 patents)

4. Brian Dolinski (5 out of 5 patents)

5. Byron Delabarre (4 out of 9 patents)

6. Mara Christine Inniss (4 out of 4 patents)

7. Grace Y Olinger (4 out of 4 patents)

8. Celeste Richardson (3 out of 4 patents)

9. Abhishek Kulkarni (3 out of 3 patents)

10. Scott Francis Heller (3 out of 3 patents)

11. Michael N Gladstone (3 out of 6 patents)

12. Dhruv Kam Sethi (2 out of 2 patents)

13. James A Storer (2 out of 2 patents)

14. Vijaya Balakrishnan (2 out of 2 patents)

15. Michelle Lynn Ols (2 out of 2 patents)

7 patents: Sort by Forward Citations

1. 12227551 - Membrane bound IL12 compositions and methods for tunable regulation (2025-02-18),

2. 12104178 - DHFR tunable protein regulation (2024-10-01),

3. 11666642 - PDE5 compositions and methods for immunotherapy (2023-06-06),

4. 11629340 - DHFR tunable protein regulation (2023-04-18),

5. 11446398 - Regulated biocircuit systems (2022-09-20),

6. 11241485 - PDE5 compositions and methods for immunotherapy (2022-02-08),

7. 11058725 - CA2 compositions and methods for tunable regulation (2021-07-13),

Obsidian Therapeutics, Inc. is a biotechnology company focused on the development of cell therapies with controllable pharmacology. Their technology platform enables precise control over the activity of engineered cells, offering potential benefits for patients in need of targeted and personalized treatments for a range of diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

7 Patents

#267 in Cambridge, MA

#2,239 in Massachusetts

#38,743 in US

Cambridge, MA, United States of America

Obsidian Therapeutics, Inc.